title: Compliance of males with stage 1 testicular germ cell tumours on an active surveillance protocol.
abstract: The aim of this retrospective study was to determine the rate of compliance among 57 males with stage 1 testicular germ cell tumours on an active surveillance protocol at a single Australian centre. At median follow up of 24 months, 81% had adequate compliance with the follow-up regimen, 12% were lost to follow up, and 16% relapsed; none between protocol visits. Active surveillance is an acceptable alternative to adjuvant therapy for stage 1 testicular germ cell tumours, with reduced toxicity for most and equivalent survival, but requires efforts to maintain adequate compliance with follow up to avoid late detection of recurrence.
authors.affiliation: Medical Oncology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
authors.forename: F
authors.initials: F
authors.lastname: Honeyball
authors.affiliation: Radiation Oncology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
authors.forename: R
authors.initials: R
authors.lastname: Murali-Ganesh
authors.affiliation: Radiation Oncology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.|Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.
authors.forename: G
authors.initials: G
authors.lastname: Hruby
authors.affiliation: Medical Oncology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.|Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.
authors.forename: P
authors.initials: P
authors.lastname: Grimison
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols; D001315:Australia; D006801:Humans; D059012:Lost to Follow-Up; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology*; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000473:pathology* / Q000628:therapy*; D010349:Patient Compliance / Q000706:statistics & numerical data*; D012189:Retrospective Studies; D013736:Testicular Neoplasms / Q000473:pathology* / Q000628:therapy*; D055815:Young Adult
keywords: compliance; stage 1; surveillance; testicular cancer